Iron Deficiency Anemia

In a final recommendation statement, the U.S. Preventative Services Task Force said there is insufficient evidence to recommend for or against the use of iron supplements during pregnancy.

Iron deficiency appeared common among a cohort of U.S. females aged 12 years to 21 years, with an overall prevalence of nearly 40%, according to study results published in a research letter in JAMA.

The FDA approved the first IV ferric carboxymaltose injection for iron deficiency in adults with heart failure to improve exercise capacity, according to a press release from American Regent.

Ferric carboxymaltose induced a higher rate of hypophosphatemia compared with ferric derisomaltose among patients with inflammatory bowel disease-associated iron deficiency anemia, according to results published in Gut.

In a video interview with Healio, Michael Auerbach, MD, FACP, discussed the importance of managing iron deficiency anemia — which he described as the most common “malady on the planet” — in pregnancy.

ASH recognized three Choosing Wisely Champions during the ASH Annual Meeting and Exposition, held last month in Atlanta.

In this Healio Gastroenterology video exclusive, Stephen B. Hanauer, MD, FACG, discussed intravenous iron products being used in the treatment iron deficiency anemia in patients with inflammatory bowel disease.

Many primary care physicians may be overusing laboratory tests for anemia screening, misinterpreting iron studies and underusing bidirectional endoscopy for new-onset iron deficiency anemia, according to a recent survey study.

The British Society of Gastroenterology published guidelines for the management of iron deficiency anemia among an adult population.

Iron replacement with IV ferumoxytol appears effective and safe for iron-deficient pregnant women with anemia in their second or third trimester, according to study results published in Therapeutic Advances in Hematology.